Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 392

1.

Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial.

Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ, Sachs DP, Wolter TD, Buist AS, Johnston JA, White JD.

Ann Intern Med. 2001 Sep 18;135(6):423-33.

PMID:
11560455
2.

A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia.

Evins AE, Cather C, Deckersbach T, Freudenreich O, Culhane MA, Olm-Shipman CM, Henderson DC, Schoenfeld DA, Goff DC, Rigotti NA.

J Clin Psychopharmacol. 2005 Jun;25(3):218-25.

PMID:
15876899
3.

A comparison of sustained-release bupropion and placebo for smoking cessation.

Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM.

N Engl J Med. 1997 Oct 23;337(17):1195-202.

4.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223
5.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
6.

The effect of bupropion sustained-release on cigarette craving after smoking cessation.

Durcan MJ, Deener G, White J, Johnston JA, Gonzales D, Niaura R, Rigotti N, Sachs DP.

Clin Ther. 2002 Apr;24(4):540-51.

PMID:
12017399
7.

Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.

Jamerson BD, Nides M, Jorenby DE, Donahue R, Garrett P, Johnston JA, Fiore MC, Rennard SI, Leischow SJ.

Clin Ther. 2001 May;23(5):744-52.

PMID:
11394732
8.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
9.

A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.

Dalsgareth OJ, Hansen NC, Søes-Petersen U, Evald T, Høegholm A, Barber J, Vestbo J.

Nicotine Tob Res. 2004 Feb;6(1):55-61.

PMID:
14982688
10.

A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse.

Covey LS, Glassman AH, Jiang H, Fried J, Masmela J, LoDuca C, Petkova E, Rodriguez K.

Addiction. 2007 Aug;102(8):1292-302.

PMID:
17624979
11.

Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants.

Chengappa KN, Kambhampati RK, Perkins K, Nigam R, Anderson T, Brar JS, Vemulapalli HK, Atzert R, Key P, Kang JS, Levine J.

J Clin Psychiatry. 2001 Jul;62(7):503-8.

PMID:
11488359
12.

Development of depression during placebo-controlled trials of bupropion for smoking cessation: case reports.

Patten CA, Rummans TA, Croghan IT, Hurt RD, Hays JT.

J Clin Psychiatry. 1999 Jul;60(7):436-41.

PMID:
10453796
13.

Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking.

Hatsukami DK, Rennard S, Patel MK, Kotlyar M, Malcolm R, Nides MA, Dozier G, Bars MP, Jamerson BD.

Am J Med. 2004 Feb 1;116(3):151-7.

PMID:
14749158
14.

Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.

Cox LS, Patten CA, Niaura RS, Decker PA, Rigotti N, Sachs DP, Buist AS, Hurt RD.

J Gen Intern Med. 2004 Aug;19(8):828-34.

15.

Triple-combination pharmacotherapy for medically ill smokers: a randomized trial.

Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Hoover DR, Carson JL.

Ann Intern Med. 2009 Apr 7;150(7):447-54.

PMID:
19349630
16.

Effects of gender on relapse prevention in smokers treated with bupropion SR.

Gonzales D, Bjornson W, Durcan MJ, White JD, Johnston JA, Buist AS, Sachs DP, Rigotti NA, Niaura R, Hays JT, Hurt RD.

Am J Prev Med. 2002 May;22(4):234-9.

PMID:
11988379
17.
18.

Bupropion for pharmacologic relapse prevention to smoking: predictors of outcome.

Hurt RD, Wolter TD, Rigotti N, Hays JT, Niaura R, Durcan MJ, Gonzales D, Sachs DP, Johnston JA, Offord KP.

Addict Behav. 2002 Jul-Aug;27(4):493-507.

PMID:
12188588
19.

Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study.

Gonzales DH, Nides MA, Ferry LH, Kustra RP, Jamerson BD, Segall N, Herrero LA, Krishen A, Sweeney A, Buaron K, Metz A.

Clin Pharmacol Ther. 2001 Jun;69(6):438-44.

PMID:
11406741
20.

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

Tonstad S, Farsang C, Klaene G, Lewis K, Manolis A, Perruchoud AP, Silagy C, van Spiegel PI, Astbury C, Hider A, Sweet R.

Eur Heart J. 2003 May;24(10):946-55.

Items per page

Supplemental Content

Support Center